EMD Millipore Corp

EMD Millipore Corp, operating as Milliporesigma, a foreign-owned subsidiary of Merck KGaA headquartered in Burlington, Massachusetts, supplies laboratory infrastructure, water purification systems, filtration products, multiplex assay kits, and maintenance services to federal agencies as a prime contractor, competing full-and-open with no set-aside posture.

EMD Millipore's federal footprint spans nearly five thousand awards since 1979, with recent activity (2022–2026) averaging 57 awards per year and total combined potential value of $306.9 million. The vendor's portfolio is characterized by consistent small-to-mid-size purchase orders and task order calls rather than large platform contracts. The company competes across 170 distinct federal agencies with no concentration in a single customer; the top five customers by award count (NIH Office of the Director, FDA, Navy Bureau of Medicine and Surgery, Army Medical Command, and NIAID) represent only 14 percent of awards. By potential value, the Department of Health and Human Services Office of the Assistant Secretary for Administration leads at $20.1 million across 98 awards, followed by NIH Office of Logistics and Acquisition Operations at $10.5 million. The Army Medical Command ranks third at $5.4 million across 113 awards. This customer breadth reflects EMD Millipore's role as a commodity supplier of routine laboratory consumables and equipment maintenance rather than a strategic technology partner to any single agency.

EMD Millipore holds two named prime IDV vehicles: a $10 million single-award Blanket Purchase Agreement with the National Institute of Mental Health (NIMH) effective through February 28, 2027, authorizing operation and maintenance items including laboratory supplies, biological materials, and water purification supplies across NIH, CDC, DoD, and FDA; and a $112.7 million indefinite delivery contract with USDA's Grain Inspection, Packers and Stockyards Administration through August 4, 2027, for maintenance and repair of Milli-Q water purification systems. The vendor also operates under the GSA Federal Supply Schedule GS24F1338C, where 949 task orders carry $4.9 million combined potential value. Additional vehicles include legacy BPAs with CDC ($107.5 thousand) and Army Medical Command ($17.2 thousand), both substantially expired or closed. Task orders under the NIMH BPA range from $14 thousand to $24 thousand; calls issued February 2024 through July 2026 reflect routine maintenance and replacement parts procurement.

Representative recent work spans the vendor's core capability set. Prime awards include a $1.27 million purchase order from HHS Office of the Assistant Secretary for Administration in January 2025 for gridded filters supporting the BioWatch biodefense program; $163 thousand from the Navy's Naval Medical Research Command in August 2025 for eight Milli-Q water purification systems; a $248 thousand CDC order in September 2023 for bead array test kits; $75 thousand from Army DEVCOM in September 2025 for a Luminex xMAP INTELLIFLEX multiplex analysis system; and $58 thousand from FDA in February 2023 for a filtration device with performance extending to February 2028. Smaller task orders under the NIMH BPA illustrate transactional ordering: $17.2 thousand in February 2026 and $16.9 thousand in March 2025 for lab supplies and water purification consumables. The vendor also subcontracts at minimal scale: two subcontract awards appear in the source — a Fluor Marine Propulsion engagement on Naval Nuclear Laboratory operations (2024–2025) and two Other Transaction Agreement awards under IGF human health and performance contracts (2025). Federal grant participation is similarly limited: one sub-award under a University of Delaware NIH grant (November 2021) for developing CHO-based upstream processes for coronavirus antigen production.

EMD Millipore's award portfolio concentration by product category reflects its identity as a laboratory consumables and equipment manufacturer. Analytical Laboratory Instrument Manufacturing (NAICS 334516) anchors 1,692 awards; Maint/Repair/Rebuild of Equipment—Instruments and Laboratory Equipment (PSC R413) accounts for 424 awards; Medical and Surgical Instruments, Equipment, and Supplies (PSC 65) covers 490 awards; and Laboratory Equipment and Supplies (PSC 65A) encompasses 2,019 awards. This distribution underscores transactional, commodity-based procurement rather than system integration or large-scale program management. Recent award trajectory has declined modestly — 63 awards in 2022 to 13 in 2026 year-to-date — reflecting the snapshot's timing (data through July 15, 2026) rather than structural change. Within the next twenty-four months, 22 awards with combined potential value of $3.2 million face recompete or completion, presenting modest near-term revenue risk and opportunity.

The vendor's corporate structure identifies Cerilliant Corporation as the parent entity. Cerilliant, also foreign-owned and headquartered in Round Rock, Texas, operates multiple business segments including Cerilliant API Services; the relationship between EMD Millipore's Merck KGaA ownership and Cerilliant's parent status is not clarified in the source, but EMD Millipore operates as an autonomous subsidiary for federal contracting purposes.

EMD Millipore competes predominantly full-and-open across civilian health, research, and defense agencies. No contract awards carry set-aside designations. The vendor's federal strategy emphasizes established relationships through GSA Schedules and recurring BPAs with leading health agencies, enabling efficient procurement of proprietary water purification and filtration products (the Milli-Q and Milliplex families) across dispersed federal laboratories. The modest size and frequency of individual awards—median values in the $10–$30 thousand range—positions EMD Millipore as a steady-state supplier of mission-critical but non-differentiating laboratory infrastructure rather than a competitive threat or teaming target for federal prime contractors pursuing large platform opportunities.